Nothing Special   »   [go: up one dir, main page]

CN106093227A - The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample - Google Patents

The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample Download PDF

Info

Publication number
CN106093227A
CN106093227A CN201610380851.2A CN201610380851A CN106093227A CN 106093227 A CN106093227 A CN 106093227A CN 201610380851 A CN201610380851 A CN 201610380851A CN 106093227 A CN106093227 A CN 106093227A
Authority
CN
China
Prior art keywords
sub
tof
phase
sample
kinds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201610380851.2A
Other languages
Chinese (zh)
Inventor
曹云峰
孙晓宇
洪沫
房中则
高鹏
赵福荣
赵欣慰
董军
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Liaoning Runsheng Kangtai Biomedical Technology Co Ltd
Original Assignee
Liaoning Runsheng Kangtai Biomedical Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Liaoning Runsheng Kangtai Biomedical Technology Co Ltd filed Critical Liaoning Runsheng Kangtai Biomedical Technology Co Ltd
Priority to CN201610380851.2A priority Critical patent/CN106093227A/en
Publication of CN106093227A publication Critical patent/CN106093227A/en
Pending legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N2030/022Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027Liquid chromatography

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)

Abstract

The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample, it belongs to bioanalytical chemistry field.The method uses after sample to be tested being pre-processed and added reaction dissolvent and extractant extraction, carries out liquid chromatography mass spectrometric detection.The method is simple to operate, selectivity is high, highly sensitive, can quickly detect 113 kinds of lipids in blood, wherein phosphatid ylcholine (PC) 48, lysophosphatidyl choline (Lyso PC) 21, phosphatidyl-ethanolamine (PE) 17, lysophosphatidyl ethanolamine (LPE) 4, haemolysis phosphinositides (PI) 6, sphingomyelins (SM) 9, ceramide (Cer) 8.The precision of the method meets the requirement of serum sample analysis, has good stability, and the detection sensitivity for major part lipid metabolin is higher, it is adaptable to the iipidomics analysis of serum sample.

Description

The LC-MS of 113 kinds of lipids in a kind of high flux detection organism blood sample Method
Technical field
The present invention relates to the LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample, it belongs to In biochemical analysis detection field, can be greatly improved with the detection carrying out 113 kinds of lipid components in blood of fast high-flux Detection efficiency and accuracy.
Background technology
Blood is important component part in human body, flows through each organ, tissue in human body, participate in human body metabolism, Regulatory function and the internal and external environment balance maintaining human body, any position of human body occurs all can produce specifically during pathologic change Biomarker is discharged in blood, and blood sample detection is noninvasive, being be easy to get most a kind of can be as in-vitro diagnosis Biological specimen, therefore routine blood test is also the detection data being the most directly easy to get in medical diagnosis[1]
At present, the metabolism group of blood is known on the early stage biomarker finding new disease day by day. 2012, the blood plasma to the 100 case patients with lung cancer collected from Moscow and 100 case healthy volunteers for the mass spectrography such as Lokhov Sample is detected.Research finds 70 metabolins related to lung cancer, and lung cancer group level is above healthy volunteer;And And the level of these metabolins just there occurs rise at the lung cancer initial stage[2].2015, Tang little Hu etc. used the generation with nuclear magnetic resonance Thank to group and learn the difference of metabolin in the Comparison between detecting methods serum sample of 51 patient with esophageal carcinoma and 50 normal persons, have found Metabolin proline is the related biomarker of the cancer of the esophagus with glutamine, and uses cluster analysis to the two biological marker Thing is verified, has finally carried out the contrast on content to the two metabolin, and discovery proline and glutamine are in the cancer of the esophagus Content in the serum of patient is all low than normal person[3].2012, Du Zhi was bravely waited and intends being suffered from by metabonomic technology detection heart failure The blood serum metabolic spectrum of person, analyzes itself and ultrasonic cardiac muscle energy consumption index MEE correlation, this research totally 61 people, wherein Normal group 15 people, heart failure group 46 people, find that 44 species diversity lipid-metabolism products are related to heart failure altogether by detection[4].Therefore blood mark Will thing is that the further investigation of disease provides effective evidence, has deep Research Significance and explores value.
Lipid compounds is the important component part of membrane structure, its cell development, energy reserve, signal conduction, Vital effect is all played during the vital movements such as matter transportation.Lipid compound includes following big class: fatty acyl Class, glyceride type, glycerophosphatide class, sphingolipid, stay alcohol lipid, isoamyl refines alcohol lipid, glycolipid class and poly ketone, different lipids The biological function of reaction is also different.Therefore, the dynamic change of lipid-metabolism can reflect lipid and metabolism thereof directly or indirectly Interaction situation between the physiology of thing and biosystem such as cell, body fluid, tissue, organ and body, pathology.In view of fat The special biological significance of matter, checks that the lipid in blood has irreplaceable importance, and fat in metabolic disease examination Matter be present in cell, organelle and extracellular body fluid such as blood plasma, bile, breast, in intestinal juice, the lipid therefore detecting in blood becomes Point also become patient go to a doctor detection when most convenient detection methods[5].The abnormal metabolism of lipid and arteriosclerosis, diabetes, Obesity, Alzheimer disease and tumour occur closely related, and iipidomic obtains in the raising with detection technique in recent years Increasing development, but the cognition of the 26S Proteasome Structure and Function that people are to lipid still far lags behind gene and protein, Main reasons is that the diversity complexity due to lipid molecular structure, and the delayed of corresponding analysis means hinders people couple The metabolism network of the overall lipid of life entity and complexity thereof and function controlling carry out the system research of scale globality[6].In order to Avoid flase drop and the missing inspection of disease, need fast and accurate detection method to take into account blood multi-analyte immunoassay simultaneously.At various points In analysis means, efficient liquid phase tandem mass spectrum, with its high flux high accuracy, has played big advantage in blood lipid context of detection. The precision of this method meets the requirement of serum sample analysis, has good stability, for the detection of major part lipid metabolin Sensitivity is higher, it is adaptable to the iipidomics analysis of serum sample.
2014, Qu Feng etc. employed two clinical queues, added up to 156 case serum samples to use high performance liquid chromatography series connection Triple level Four bar mass spectrums establish the quantitative analysis method of a set of targeting sheath iipidomic, retrieve (Lipid by internet database Maps) 43 sphingolipid metabolism network core compounds of identification and analysis, have carried out chronic third venereal disease virus hepatitis associated biomolecule mark Research in terms of will thing[7].2013, practise the analysis method that acute hearing etc. uses high performance liquid chromatography tandem mass spectrum to set up, carried out 80 Example type-II diabetes patient and the iipidomic research of 28 case healthy volunteer's serum samples, examine with type-II diabetes to find Break, treat closely related potential lipid biomarker.Retrieve (Lipid maps, METLIN) by internet database And the cleavage of mass spectrum feature of metabolite structures, infer the possible structure of possible biomarker.Result identifies 35 and two types The structure of the closely related lipid potential source biomolecule mark of diabetes diagnosis, additionally identifies 49 and treats with type-II diabetes The structure of closely related lipid potential source biomolecule mark[8].Jeanson L etc. use iipidomic method to describe blood plasma Network metabolic alterations in pulmonary cystic fibrosis for the lipid, the pathogenesis of pulmonary cystic fibrosis and cystic fibrosis transmembrane transmit Regulatory factor gene mutation causes airway mucus to block, bacteria planting, and lung necrosis progrediens is relevant.The pulmonary cystic fiber of research discovery Changing multiple PC and LPC in patients blood plasma all to significantly reduce, this shows that the change of phospholipid metabolism in blood plasma is sick to pulmonary cystic fibrosis Change process plays an important role, and is the potential target spot of drug therapy[9]
In the blood detecting of current existing report, lipid quantity is all less, or simply single a certain lipoid The different detecting instrument using in matter, and different report detects the disunity of the testing result causing, and many counting methods knot The means such as conjunction metabolism correlation networks analysis and database retrieval, the structure of the possible biomarker of analysis deduction, and non-usage Standard items are pointed out, and result accuracy remains to be discussed, it is impossible to provide authentic and valid examination criteria.Also there is not a kind of pre-treatment of use Detect 113 kinds of lipids of seven classes the report using whole standard items to point out by the technology of Liquid Chromatography-Tandem Mass Spectrometry after method simultaneously Road.
[1]. Fan Shaojuan. the optical joint detection method of blood biomarker is explored. Tianjin. University Of Tianjin, 2013.
[2]. Lokhov PG, Trifonova OP, Maslov DL, Archakov AI. Blood plasma Metabolites and the risk of developing lung cancer in Russia. [ J ]. Eur J Cancer Prev. 2013 Jul; 22(4):335-41.
[3]. Tang little Hu. find cancer of the esophagus biomarker based on metabolism group and the resistant organism mark of lung cancer grinds Study carefully. Beijing. Beijing University of Chemical Technology, 2015.
[4]. Du Zhiyong. metabolism group method evaluates the basic and clinic studies of chronic heart failure metabolism reconstruct. [ D ]. Guangdong Province: south medical courses in general are big, 2012.
[5]. Cai Tanxi. Liu Pingsheng. Yang Fuquan. Yang Fuyu. iipidomic progress. biochemistry and biophysics Progress, 2010,37 (2): 121-128.
[6]. Ma little Qiong, lipidomics and neurolipidomics are in progress [J], Chinese J Pharmacol Toxicol, and 2008,22 (2):156-160.
[7]. Qu Feng. iipidomics analysis technology and in discovery immunity disease and virus hepatitis associated biomarkers The research of aspect. [ D ]. Beijing: Beijing Union Medical College, 2014.
[8]. practise acute hearing, based on the patients with type Ⅰ DM serum lipids group research of technology. Beijing. Beijing Union Medical College, 2013.
[9]. Jeanson L, Guerrera IC, Papon JF, Chhuon C, Zadigue P, et. al. Proteomic analysis of nasal epithelial cells from cystic fibrosis patients. J ]. PLoS One. 2014 Sep 30;9(9).
Content of the invention
For solving problems of the prior art, the present invention provides 113 kinds of lipids in a kind of high flux detection blood LC-MS method, provides a kind of detection efficiency height, degree of accuracy lipid detection technique accurately.Use high performance liquid chromatography (HPLC) separate, electric spray ion source high-resolution time-of-flight mass spectrometry (ESI-Q-TOF-MS) measures in biological sample simultaneously The composition of 113 kinds of lipid compounds.Wherein, high performance liquid chromatography with the methanol-water solution containing formic acid for flowing phase, electron spray from Component high-resolution time-of-flight mass spectrometry uses internal standard method, carries out 113 kinds of lipid compounds qualitative simultaneously and analyzes.
The technical solution used in the present invention is: the liquid matter of 113 kinds of lipids in a kind of high flux detection organism blood sample Method for combined use, uses Ultra Performance Liquid Chromatography to separate and electric spray ion source high-resolution time-of-flight mass spectrometry (ESI-Q- TOF-MS) range of lipids composition detection in sample is analyzed by positive and negative ion scan pattern.Including phosphatid ylcholine (PC), haemolysis Phosphatid ylcholine (Lyso-PC), phosphatidyl-ethanolamine (PE), lysophosphatidyl choline (Lyso-PC), haemolysis phosphinositides (Lyso-PI), sphingomyelins (SM), ceramide (ceramide) amount to 7 constituents, totally 113 kinds of lipid monomeric compounds.
(1) foundation of reference material database
According to the ionized form under ESI source and chemical formula, obtain the accurate mass number of every kind of compound parent ion, form TOF/ MS database.Under Q-TOF/MS pattern, gather fragment ion under 3 different collision energies for the every kind of lipid reference material respectively Mass spectrogram, forms Q-TOF/MS database;Described 3 different collision energies are respectively as follows: 20psi, 35psi and 50psi;Standard items The dilution of inner mark solution is 80% methanol aqueous solution;
(2) biological blood sample process
1) take frozen blood plasma at-80 DEG C, thaw in 4 DEG C of refrigerators, take 10 μ L blood plasma, be sequentially added into 10 μ L mixing inner mark solutions, 10 μ L 0.9% NaCl, 100 μ L extracts, vortex 20s stands 30min after 4 DEG C of refrigerators, and described extract is volume ratio 2:1 The mixed liquor of chloroform and methyl alcohol;Described mixing inner mark solution is phosphatid ylcholine containing 19:0-19:0,17:0-17:0 phosphatide Acyl monoethanolamine, 12:0 sphingomyelins, 19:0 lysophosphatidyl choline, concentration is the isopropanol-acetonitrile solution of 5 μ g/mL, different Propyl alcohol, the ratio of acetonitrile are 1:1;
2) after taking standing, sample 7800g/min centrifuges 3min, with 1mL syringe absorption subnatant in 0.5mLEP pipe, inhales at once Take 40 μ L in internal lining pipe, nitrogen seal after drying up be stored in-20 DEG C of refrigerators stand-by;
3) with 40 μ L acetonitriles before sample introduction: isopropanol volume ratio is that the mixed liquor of 1:1 redissolves, vortex 60s, sample introduction;
(3) qualitative detection
Use HPLC/ESI-Q-TOF-MS determination step 3) in blood sample treatment fluid, by comparison sample retain when Between, first mass spectrometric and second order ms information, determine whether sample contains 113 kinds of target lipid components;
Chromatographic condition: column temperature: 50 DEG C, Sample Room temperature: 4 DEG C, flow velocity: 0.4 mL/min, sampling volume: 2 μ L, flow phase: A Phase: 10 mmoL/L ammonium acetate+0.1% formic acid+99.9% water, B phase: 10 mmoL/L ammonium acetate+0.1% formic acid+49.95% acetonitriles + 49.95% isopropanol gradient elution.
Described gradient elution program is: 65/35(A/B, V/V during 0.01min), gradually change gradient and become 20/ to 2min 80(A/B, V/V), change gradient further and become 0/100(A/B, V/V to 9min), and maintain 15min, become to 16min Initial concentration 65/35(A/B, V/V) and maintain 20min.
Cation detection Mass Spectrometry Conditions is: ion gun: ESI source;Ion spray voltage :+5.5kV;Turbine injection temperation (TEM): 550 DEG C;GS1:50 psi;GS2:50 psi;CUR:30psi;TOF MS and TOF MS/MS sweep limits are respectively For: m/z 100 1500 and 50 1200.Anionic textiles Mass Spectrometry Conditions is: ion gun: ESI source;Ion spray voltage :- 4.5kV;Turbine injection temperation (TEM): 550 DEG C;GS1:50 psi;GS2:50 psi;CUR:30psi;TOF MS and TOF- MS/MS sweep limits is respectively as follows: m/z 200 1200 and 50 1200.
(4) relative quantification detection
With phosphatid ylcholine containing 19:0-19:0,17:0-17:0 phosphatidyl-ethanolamine, 12:0 sphingomyelins, 19:0 lysophosphatide Isopropanol-the acetonitrile solution of phatidylcholine is internal standard, carries out relative quantification to the lipid components detecting in biological sample, at sample Preprocessing process adds the internal standard compound that concentration determines, 19:0-19:0 phosphatid ylcholine, 17:0-17:0 phosphatidyl second Hydramine, 12:0 sphingomyelins, 19:0 lysophosphatidyl choline, use peak area ratio method, the compound of each class corresponding its Internal standard carries out relative quantification, if target in not corresponding, uses the principle that retention time is close to select internal standard to carry out relative quantification.
This patent method determines ionized form and chemical formula under this 113 kinds of compound ESI sources, obtains every kind of compound Accurate mass number in negative ions collection for the parent ion, forms TOF/MS database.Under Q-TOF/MS pattern, gather respectively Fragment ion mass spectrogram under the different collision energy of the positive and negative drainage pattern of every kind of lipid reference material, forms Q-TOF/MS database.
HPLC/ESI-Q-TOF-MS is used to measure biological sample treatment fluid, by retention time, one-level matter in comparison sample Spectrum and second order ms information, determine whether contain 113 kinds of target lipid components in sample.
Chromatographic condition
Column temperature: 50 DEG C of Sample Room temperature: 4 DEG C of flow velocitys: 0.4 mL/min sampling volume: 2 μ L
Flowing phase: A:10 mmoL/L ammonium acetate+0.1% formic acid+99.9% water
B:10 mmoL/L ammonium acetate+0.1% formic acid+49.95% acetonitrile+49.95% isopropanol
Condition of gradient elution:
Time(min) A% B%
0.01 65 35
2 20 80
9 0 100
15 0 100
16 65 35
20 65 35
Mass spectrometry method
Positive ion mode parameter is arranged
Parameter TOF MS(+) Product Ion(+)IDA
Atomization gas 50 50
Auxiliary gas 50 50
Gas curtain gas 30 30
Atomization temperature 550 550
Spray voltage 5500 5500
Sweep limits 100-1500 50-1200
Remove a bunch voltage 80 80
Collision energy 10 35
Collision voltage difference ---- 15
Ion Release Delay(IRD) ---- 67
Ion Release Width(IRW) ---- 25
Negative ion mode parameter is arranged
Parameter TOF MS(-) Product Ion(-)IDA
Atomization gas 50 50
Auxiliary gas 50 50
Gas curtain gas 30 30
Atomization temperature 550 550
Spray voltage 4500 4500
Sweep limits 200-1200 50-1200
Remove a bunch voltage -80 -80
Collision energy -10 -35
Collision voltage difference ---- 15
Ion Release Delay(IRD) ---- 67
Ion Release Width(IRW) ---- 25
The application provides the benefit that: the method uses and sample to be tested pre-processed and added reaction dissolvent and extractant extraction After, carry out liquid phase-Mass Spectrometer Method.The method is simple to operate, selectivity is high, highly sensitive, can quickly detect 113 kinds of fat in blood Matter, wherein phosphatid ylcholine (PC) 48, lysophosphatidyl choline (Lyso-PC) 21, phosphatidyl-ethanolamine (PE) 17, molten Serium inorganic phosphorus acyl monoethanolamine (LPE) 4, haemolysis phosphinositides (PI) 6, sphingomyelins (SM) 9, ceramide (Cer) 8. The method simultaneously qualitative and quantitative can detect 113 kinds of lipids, and detection sensitivity is high.The precision of this method meets serum sample one's duty Analysis requirement, have good stability, for major part lipid metabolin detection sensitivity higher, it is adaptable to the fat of serum sample Matter group credit is analysed.
Brief description
Fig. 1 is lipid standard items LC-TOF-MS cation drainage pattern TIC chromatogram of the present invention.
Fig. 2 is lipid standard items LC-TOF-MS anion drainage pattern TIC chromatogram of the present invention.
Fig. 3 is blood sample lipid detection LC-TOF-MS cation drainage pattern TIC chromatogram in the actual application of the present invention Figure.
Fig. 4 is blood sample lipid detection LC-TOF-MS anion drainage pattern TIC chromatogram in the actual application of the present invention Figure.
Fig. 5 is lipid standard items LC-TOF-MS cation drainage pattern XIC chromatogram of the present invention.
Specific embodiments
Lipid species detection in one haemophiliac's blood
1) internal standard liquid and extract preparation
Inner mark solution: PC containing 19:0-19:0,17:0-17:0 PE, 12:0 SM, 19:0 Lyso PC concentration are 5 μ g/mL Isopropanol-acetonitrile solution (1:1).Extract: chloroform-methanol (2:1).
2) patient blood samples's process
Patient blood samples's process, frozen blood plasma at-80 DEG C, thaws in 4 DEG C of refrigerators, takes 10 μ L blood plasma, be sequentially added into 10 μ L Mixing inner mark solution, 10 μ L 0.9%NaCl, 100 μ L chloroform-methanol (2:1) extracts, vortex 20s, 4 DEG C of refrigerators stand 30min.7800g/min centrifuges 3min.1mL syringe absorption subnatant, in 0.5mLEP pipe, draws 40 μ L at once in internal lining pipe In.Nitrogen dries up, and sealing is stored in-20 DEG C of refrigerators stand-by.Redissolve with 40 μ L acetonitriles-isopropanol (1:1) before sample introduction, vortex 60s, Sample introduction.
3) standard items Database
Use HPLC/ESI-Q-TOF-MS to survey 113 kinds of lipid standard items mixed solutions in blood, determine this 113 kinds of compounds Ionized form under ESI source and chemical formula, obtain the accurate mass number of every kind of compound parent ion, forms TOF/MS data Storehouse.Under Q-TOF/MS pattern, gather fragment under the different collision energy of 35 ± 15psi tri-for the every kind of lipid reference material respectively Ion massspectrum figure, forms Q-TOF/MS database.
4) qualitative detection
Use HPLC/ESI-Q-TOF-MS determination step 2) in blood sample treatment fluid, cation detection Mass Spectrometry Conditions be: from Component: ESI source;Ion spray voltage :+5.5kV;Turbine injection temperation (TEM): 550 DEG C;GS1:50 psi;GS2:50 psi; CUR:30psi;TOF MS and TOF MS/MS sweep limits are respectively as follows: m/z 100 1500 and 50 1200.Anion is examined Surveying Mass Spectrometry Conditions is: ion gun: ESI source;Ion spray voltage :-4.5kV;Turbine injection temperation (TEM): 550 DEG C;GS1:50 psi;GS2:50 psi;CUR:30psi;TOF MS and TOF-MS/MS sweep limits are respectively as follows: m/z 200 1200 and 50 1200。
By retention time, first mass spectrometric and second order ms information in comparison sample, determine in human serum sample whether contain Having 113 kinds of target lipid components, testing result sees attached list the 2nd, 3.
5) quantitatively detect
Subordinate list 1:113 kind lipid standard items essential information
Numbering Trade name Molecular formula Cation m/z Anion m/z
1 Egg Lyso PC C<sub>24</sub>H<sub>50</sub>NO<sub>7</sub>P 496.3398 540.3296
2 Soy Lyso PC C<sub>24</sub>H<sub>50</sub>NO<sub>7</sub>P 496.3398 540.3296
3 06:0 Lyso PC C<sub>14</sub>H<sub>30</sub>NO<sub>7</sub>P 356.1833 400.1731
4 07:0 Lyso PC C<sub>15</sub>H<sub>32</sub>NO<sub>7</sub>P 370.1989 414.1887
5 08:0 Lyso PC C<sub>16</sub>H<sub>34</sub>NO<sub>7</sub>P 384.2146 428.2044
6 09:0 Lyso PC C<sub>17</sub>H<sub>36</sub>NO<sub>7</sub>P 398.2302 442.2200
7 10:0 Lyso PC C<sub>18</sub>H<sub>38</sub>NO<sub>7</sub>P 412.2459 456.2357
8 11:0 Lyso PC C<sub>19</sub>H<sub>40</sub>NO<sub>7</sub>P 426.2615 470.2513
9 12:0 Lyso PC C<sub>20</sub>H<sub>42</sub>NO<sub>7</sub>P 440.2772 484.2670
10 13:0 Lyso PC C<sub>21</sub>H<sub>44</sub>NO<sub>7</sub>P 454.2928 498.2826
11 14:0 Lyso PC C<sub>22</sub>H<sub>46</sub>NO<sub>7</sub>P 468.3085 512.2983
12 15:0 Lyso PC C<sub>23</sub>H<sub>48</sub>NO<sub>7</sub>P 482.3241 526.3139
13 16:0 Lyso PC C<sub>24</sub>H<sub>50</sub>NO<sub>7</sub>P 496.3398 540.3296
14 17:0 Lyso PC C<sub>25</sub>H<sub>52</sub>NO<sub>7</sub>P 510.3554 554.3452
15 18:0 Lyso PC C<sub>26</sub>H<sub>54</sub>NO<sub>7</sub>P 524.3711 568.3609
16 18:1 Lyso PC C<sub>26</sub>H<sub>52</sub>NO<sub>7</sub>P 522.3554 566.3452
17 19:0 Lyso PC C<sub>27</sub>H<sub>56</sub>NO<sub>7</sub>P 538.3867 582.3765
18 20:0 Lyso PC C<sub>28</sub>H<sub>58</sub>NO<sub>7</sub>P 552.4024 596.3922
19 22:0 Lyso PC C<sub>30</sub>H<sub>62</sub>NO<sub>7</sub>P 580.4337 624.4235
20 24:0 Lyso PC C<sub>32</sub>H<sub>66</sub>NO<sub>7</sub>P 608.4650 652.4548
21 26:0 Lyso PC C<sub>34</sub>H<sub>70</sub>NO<sub>7</sub>P 636.4963 680.4861
22 13:0 Lyso PI C<sub>22</sub>H<sub>46</sub>NO<sub>12</sub>P 548.2830 529.2408
23 16:0 Lyso PI C<sub>25</sub>H<sub>52</sub>NO<sub>12</sub>P 590.3300 571.2877
24 18:0 Lyso PI C<sub>27</sub>H<sub>56</sub>NO<sub>12</sub>P 618.3613 599.31909
25 17:1 Lyso PI C<sub>26</sub>H<sub>52</sub>NO<sub>12</sub>P 602.3300 583.2877
26 18:1 Lyso PI C<sub>27</sub>H<sub>54</sub>NO<sub>12</sub>P 616.3456 597.3034
27 20:4 Lyso PI C<sub>29</sub>H<sub>52</sub>NO<sub>12</sub>P 638.3300 619.2877
28 06:0 PE C<sub>17</sub>H<sub>34</sub>NO<sub>8</sub>P 412.2095 410.1949
29 08:0 PE C<sub>21</sub>H<sub>42</sub>NO<sub>8</sub>P 468.2721 466.2575
30 10:0 PE C<sub>25</sub>H<sub>50</sub>NO<sub>8</sub>P 524.3347 522.3201
31 12:0 PE C<sub>29</sub>H<sub>58</sub>NO<sub>8</sub>P 580.3973 578.3827
32 14:0 PE C<sub>33</sub>H<sub>66</sub>NO<sub>8</sub>P 636.4599 634.4453
33 15:0 PE C<sub>35</sub>H<sub>70</sub>NO<sub>8</sub>P 664.4912 662.4766
34 16:0 PE C<sub>37</sub>H<sub>74</sub>NO<sub>8</sub>P 692.5225 690.5079
35 17:0 PE C<sub>39</sub>H<sub>78</sub>NO<sub>8</sub>P 720.5538 718.5392
36 18:0 PE C<sub>41</sub>H<sub>82</sub>NO<sub>8</sub>P 748.5851 746.5705
37 16:0-18:1 PE C<sub>39</sub>H<sub>76</sub>NO<sub>8</sub>P 718.5381 716.5235
38 16:0-18:2 PE C<sub>39</sub>H<sub>74</sub>NO<sub>8</sub>P 716.5225 714.5079
39 16:0-20:4 PE C<sub>41</sub>H<sub>74</sub>NO<sub>8</sub>P 740.5225 738.5079
40 16:0-22:6 PE C<sub>43</sub>H<sub>74</sub>NO<sub>8</sub>P 764.5225 762.5079
41 18:0-18:1 PE C<sub>41</sub>H<sub>80</sub>NO<sub>8</sub>P 746.5694 744.5548
42 18:0-18:2 PE C<sub>41</sub>H<sub>78</sub>NO<sub>8</sub>P 744.5538 742.5392
43 18:0-20:4 PE C<sub>43</sub>H<sub>78</sub>NO<sub>8</sub>P 768.5538 766.5392
44 18:0-22:6 PE C<sub>45</sub>H<sub>78</sub>NO<sub>8</sub>P 792.5538 790.5392
45 14:0 Lyso PE C<sub>19</sub>H<sub>40</sub>NO<sub>7</sub>P 426.2615 424.2469
46 16:0 Lyso PE C<sub>21</sub>H<sub>44</sub>NO<sub>7</sub>P 454.2928 452.2782
47 18:0 Lyso PE C<sub>23</sub>H<sub>48</sub>NO<sub>7</sub>P 482.3241 480.3095
48 18:1 Lyso PE C<sub>23</sub>H<sub>46</sub>NO<sub>7</sub>P 480.3085 478.2939
49 03:0 PC C<sub>14</sub>H<sub>28</sub>NO<sub>8</sub>P 370.1625 414.1523
50 04:0 PC C<sub>16</sub>H<sub>32</sub>NO<sub>8</sub>P 398.1938 442.1836
51 05:0 PC C<sub>18</sub>H<sub>36</sub>NO<sub>8</sub>P 426.2251 470.2149
52 06:0 PC (DHPC) C<sub>20</sub>H<sub>40</sub>NO<sub>8</sub>P 454.2564 498.2462
53 07:0 PC (DHPC) C<sub>22</sub>H<sub>44</sub>NO<sub>8</sub>P 482.2877 526.2775
54 08:0 PC C<sub>24</sub>H<sub>48</sub>NO<sub>8</sub>P 510.319 554.3088
55 09:0 PC C<sub>26</sub>H<sub>52</sub>NO<sub>8</sub>P 538.3503 582.3401
56 10:0 PC C<sub>28</sub>H<sub>56</sub>NO<sub>8</sub>P 566.3816 610.3714
57 11:0 PC C<sub>30</sub>H<sub>60</sub>NO<sub>8</sub>P 594.4129 638.4027
58 12:0 PC (DLPC) C<sub>32</sub>H<sub>64</sub>NO<sub>8</sub>P 622.4442 666.4340
59 13:0 PC C<sub>34</sub>H<sub>68</sub>NO<sub>8</sub>P 650.4755 694.4653
60 14:0 PC (DMPC) C<sub>36</sub>H<sub>72</sub>NO<sub>8</sub>P 678.5068 722.4966
61 15:0 PC C<sub>38</sub>H<sub>76</sub>NO<sub>8</sub>P 706.5381 750.5279
62 16:0 PC (DPPC) C<sub>40</sub>H<sub>80</sub>NO<sub>8</sub>P 734.5694 778.5592
63 17:0 PC C<sub>42</sub>H<sub>84</sub>NO<sub>8</sub>P 762.6007 806.5905
64 18:0 PC (DSPC) C<sub>44</sub>H<sub>88</sub>NO<sub>8</sub>P 790.632 834.6218
65 19:0 PC C<sub>46</sub>H<sub>92</sub>NO<sub>8</sub>P 818.6633 862.6531
66 20:0 PC C<sub>48</sub>H<sub>96</sub>NO<sub>8</sub>P 846.6946 890.6844
67 21:0 PC C<sub>50</sub>H<sub>100</sub>NO<sub>8</sub>P 874.7259 918.7157
68 22:0 PC C<sub>52</sub>H<sub>104</sub>NO<sub>8</sub>P 902.7572 946.7470
69 23:0 PC C<sub>54</sub>H<sub>108</sub>NO<sub>8</sub>P 930.7885 974.7783
70 24:0 PC C<sub>56</sub>H<sub>112</sub>NO<sub>8</sub>P 958.8198 1002.8096
71 14:1 (Δ9-Cis) PC C<sub>36</sub>H<sub>68</sub>NO<sub>8</sub>P 674.4755 718.4653
72 14:1 (Δ9-Trans) PC C<sub>36</sub>H<sub>68</sub>NO<sub>8</sub>P 674.4755 718.4653
73 16:1 (Δ9-Cis) PC C<sub>40</sub>H<sub>76</sub>NO<sub>8</sub>P 730.5381 774.5279
74 16:1 (Δ9-Trans) PC C<sub>40</sub>H<sub>76</sub>NO<sub>8</sub>P 730.5381 774.5279
75 18:1 (Δ6-Cis) PC C<sub>44</sub>H<sub>84</sub>NO<sub>8</sub>P 786.6007 830.5905
76 18:1 (Δ9-Cis) PC (DOPC) C<sub>44</sub>H<sub>84</sub>NO<sub>8</sub>P 786.6007 830.5905
77 18:1 (Δ9-Trans) PC C<sub>44</sub>H<sub>84</sub>NO<sub>8</sub>P 786.6007 830.5905
78 18:2 (Cis) PC (DLPC) C<sub>44</sub>H<sub>80</sub>NO<sub>8</sub>P 782.5694 826.5592
79 18:3 (Cis) PC C<sub>44</sub>H<sub>76</sub>NO<sub>8</sub>P 778.5381 822.5279
80 20:1 (Cis) PC C<sub>48</sub>H<sub>92</sub>NO<sub>8</sub>P 842.6633 886.6531
81 20:4 (Cis) PC C<sub>48</sub>H<sub>80</sub>NO<sub>8</sub>P 830.5694 874.5592
82 22:1 (Cis) PC C<sub>52</sub>H<sub>100</sub>NO<sub>8</sub>P 898.7259 942.7157
83 22:6 (Cis) PC C<sub>52</sub>H<sub>80</sub>NO<sub>8</sub>P 878.5694 922.5592
84 24:1 (Cis) PC C<sub>56</sub>H<sub>108</sub>NO<sub>8</sub>P 954.7885 998.7783
85 14:0-16:0 PC C<sub>38</sub>H<sub>76</sub>NO<sub>8</sub>P 706.5381 750.5279
86 14:0-18:0 PC C<sub>40</sub>H<sub>80</sub>NO<sub>8</sub>P 734.5694 778.5592
87 16:0-02:0 PC C<sub>26</sub>H<sub>52</sub>NO<sub>8</sub>P 538.3503 582.3401
88 16:0-14:0 PC C<sub>38</sub>H<sub>76</sub>NO<sub>8</sub>P 706.5381 750.5279
89 16:0-18:0 PC C<sub>42</sub>H<sub>84</sub>NO<sub>8</sub>P 762.6007 806.5905
90 16:0-18:1 PC C<sub>42</sub>H<sub>82</sub>NO<sub>8</sub>P 760.5851 804.5749
91 18:0-18:2 PC C<sub>44</sub>H<sub>84</sub>NO<sub>8</sub>P 786.6007 830.5905
92 18:0-20:4 PC C<sub>46</sub>H<sub>84</sub>NO<sub>8</sub>P 810.6007 854.5905
93 18:0-22:6 PC C<sub>48</sub>H<sub>84</sub>NO<sub>8</sub>P 834.6007 878.5905
94 18:1-14:0 PC C<sub>40</sub>H<sub>78</sub>NO<sub>8</sub>P 732.5538 776.5436
95 18:1-16:0 PC C<sub>42</sub>H<sub>82</sub>NO<sub>8</sub>P 760.5851 804.5749
96 18:1-18:0 PC C<sub>44</sub>H<sub>86</sub>NO<sub>8</sub>P 788.6164 832.6062
97 02:0 SM (d18:1/2:0) C<sub>25</sub>H<sub>51</sub>N<sub>2</sub>O<sub>6</sub>P 507.3558 551.3455
98 06:0 SM (d18:1/6:0) C<sub>29</sub>H<sub>59</sub>N<sub>2</sub>O<sub>6</sub>P 563.4184 607.4081
99 12:0 SM (d18:1/12:0) C<sub>35</sub>H<sub>71</sub>N<sub>2</sub>O<sub>6</sub>P 647.5123 691.5020
100 16:0 SM (d18:1/16:0) C<sub>39</sub>H<sub>79</sub>N<sub>2</sub>O<sub>6</sub>P 703.5749 747.5646
101 17:0 SM (d18:1/17:0) C<sub>40</sub>H<sub>81</sub>N<sub>2</sub>O<sub>6</sub>P 717.5905 761.5803
102 18:0 SM (d18:1/18:0) C<sub>41</sub>H<sub>83</sub>N<sub>2</sub>O<sub>6</sub>P 731.6062 775.5959
103 18:1 SM (d18:1/18:1(9Z)) C<sub>41</sub>H<sub>81</sub>N<sub>2</sub>O<sub>6</sub>P 729.5905 773.5803
104 24:0 SM C<sub>47</sub>H<sub>95</sub>N<sub>2</sub>O<sub>6</sub>P 815.7001 859.6898
105 24:1 SM C<sub>47</sub>H<sub>93</sub>N<sub>2</sub>O<sub>6</sub>P 813.6844 857.6742
106 16:0 ceramide C34H67NO3 560.5013 582.5092
107 18:0 ceramide C36H71NO3 588.5326 610.5405
108 18:1 ceramide C36H69NO3 586.517 608.5249
109 19:0 ceramide C37H73NO3 602.5483 624.5562
110 20:0 ceramide C38H75NO3 616.5639 638.5718
111 22:0 ceramide C40H79NO3 644.5952 666.6031
112 24:0 ceramide C42H83NO3 672.6265 694.6344
113 24:1 ceramide C42H81NO3 670.6109 692.6188
Subordinate list 2: haemophiliac's serum lipids positive ion mode testing result
Subordinate list 3: haemophiliac's serum lipids negative ion mode testing result

Claims (3)

1. high flux detects a LC-MS method for 113 kinds of lipids in organism blood sample, uses ultra high efficiency liquid phase look Spectrum separates with electric spray ion source high-resolution time-of-flight mass spectrometry (ESI-Q-TOF-MS) positive and negative ion scan pattern to sample In Ben, range of lipids composition detection is analyzed, it is characterised in that said method comprising the steps of:
(1) foundation of reference material database
According to the ionized form under ESI source and chemical formula, obtain the accurate mass number of every kind of compound parent ion, form TOF/ MS database;Under Q-TOF/MS pattern, gather fragment ion under 3 different collision energies for the every kind of lipid reference material respectively Mass spectrogram, forms Q-TOF/MS database;
(2) biological blood sample process
Take blood plasma and add mixing inner mark solution, add extract, centrifugal;Take off clear, after nitrogen dries up, add redissolution liquid to carry out Redissolve, obtain testing sample;Described extract is the mixed liquor with methyl alcohol for the chloroform of volume ratio 2:1;Described mixing inner mark solution For phosphatid ylcholine containing 19:0-19:0,17:0-17:0 phosphatidyl-ethanolamine, 12:0 sphingomyelins, 19:0 hemolytic phosphatidyl courage Alkali concn is the isopropanol-acetonitrile solution of 5 μ g/mL;Described redissolution liquid is acetonitrile: isopropanol volume ratio is the mixing of 1:1 Liquid;
(3) qualitative detection
HPLC/ESI-Q-TOF-MS is used to measure testing sample, by retention time, first mass spectrometric and two grades in comparison sample Information in Mass Spectra, determines whether contain 113 kinds of target lipid components in sample;
HPLC chromatogram condition: column temperature: 50 DEG C, Sample Room temperature: 4 DEG C, flow velocity: 0.4 mL/min, sampling volume: 2 μ L, flowing Phase: A phase: ammonium acetate containing 10mM/L, the water of volume fraction 0.1% formic acid, B phase: ammonium acetate containing 10mM/L, volume fraction 0.1% first Acetonitrile-isopropanol the mixed liquor of acid, acetonitrile in acetonitrile-isopropanol mixed liquor: the volume ratio of isopropanol is 1:1, eluent gradient Wash-out;
Cation detection Mass Spectrometry Conditions is: ion gun: ESI source;Ion spray voltage :+5.5kV;Turbine injection temperation (TEM): 550℃;GS1:50 psi;GS2:50 psi;CUR:30psi;TOF MS and TOF MS/MS sweep limits are respectively as follows: m/z 100 1500 and 50 1200;
Anionic textiles Mass Spectrometry Conditions is: ion gun: ESI source;Ion spray voltage :-4.5kV;Turbine injection temperation (TEM): 550℃;GS1:50 psi;GS2:50 psi;CUR:30psi;TOF MS and TOF-MS/MS sweep limits are respectively as follows: m/z 200 1200 and 50 1200.
2. a kind of high flux according to claim 1 detects the LC-MS side of 113 kinds of lipids in organism blood sample Method, it is characterised in that: it also include lipid relative quantification detection, detection method for phosphatid ylcholine containing 19:0-19:0, 17:0-17:0 phosphatidyl-ethanolamine, 12:0 sphingomyelins, the isopropanol-acetonitrile solution of 19:0 lysophosphatidyl choline are interior Mark, carries out relative quantification to the lipid components detecting in biological sample, uses peak area ratio method, the compound of each class Its internal standard corresponding carries out relative quantification, if target in not corresponding, uses the principle that retention time is close to select internal standard to carry out phase To quantitatively.
3. a kind of high flux according to claim 1 detects the LC-MS side of 113 kinds of lipids in organism blood sample Method, it is characterised in that: described gradient elution program is: during 0.01min, the volume ratio of A phase/B phase is 65/35, gradually changes gradient The volume ratio becoming A phase/B phase to 2min is 20/80, and the volume ratio that change gradient becomes A phase/B phase to 9min further is 0/ 100, and maintain 15min, the volume ratio becoming initial concentration A phase/B phase to 16min is 65/35 and maintains 20min.
CN201610380851.2A 2016-06-01 2016-06-01 The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample Pending CN106093227A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201610380851.2A CN106093227A (en) 2016-06-01 2016-06-01 The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201610380851.2A CN106093227A (en) 2016-06-01 2016-06-01 The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample

Publications (1)

Publication Number Publication Date
CN106093227A true CN106093227A (en) 2016-11-09

Family

ID=57230130

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201610380851.2A Pending CN106093227A (en) 2016-06-01 2016-06-01 The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample

Country Status (1)

Country Link
CN (1) CN106093227A (en)

Cited By (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107085061A (en) * 2017-05-22 2017-08-22 天津市第三中心医院 The absolute quantification analysis method of lysophosphatidyl choline based on HPLC MS/MS detection platforms
CN107389847A (en) * 2017-06-05 2017-11-24 中国农业科学院蜜蜂研究所 A kind of method of lipid component in quick analysis Bee Pollen
CN107632095A (en) * 2017-09-19 2018-01-26 中山大学 A kind of detection method of crop glycolipid and phosphatide
CN107957467A (en) * 2017-12-13 2018-04-24 上海景峰制药有限公司 A kind of method of lysophosphatidyl choline in separation determination pharmaceutical preparation
CN108181387A (en) * 2017-12-20 2018-06-19 烟台东诚药业集团股份有限公司 The new method of phospholipid fraction content detection in a kind of Curosurf bulk pharmaceutical chemicals
CN108845051A (en) * 2018-06-22 2018-11-20 中国农业科学院农业质量标准与检测技术研究所 A method of based on sphingolipid in UHPLC-QTrap MS detection zebra fish brain tissue
CN109001360A (en) * 2018-10-09 2018-12-14 南京财经大学 A kind of method of high-throughput detection phospholipid in lipid content
CN109813813A (en) * 2019-01-18 2019-05-28 中国农业科学院农业质量标准与检测技术研究所 Method for identifying UHT milk and reconstituted milk based on lipidome
CN109870536A (en) * 2017-12-05 2019-06-11 中国科学院大连化学物理研究所 A high-coverage lipidomic analysis method based on liquid chromatography-mass spectrometry
CN109884200A (en) * 2019-02-22 2019-06-14 嘉兴迈维代谢生物科技有限公司 A kind of quick exploitation and the method for establishing standard items LC-MS database
CN109946390A (en) * 2017-12-20 2019-06-28 上海生物信息技术研究中心 A kind of combination of pulmonary cancer diagnosis marker and application
CN110007032A (en) * 2019-04-30 2019-07-12 江南大学 A kind of phospholipid detection method and application
CN110068638A (en) * 2019-05-21 2019-07-30 中山大学孙逸仙纪念医院 A kind of method of acid sphingolipid and glycosphingolipid in special separation and concentration human serum
CN110243956A (en) * 2019-05-20 2019-09-17 北京三元食品股份有限公司 A kind of food lipids extraction and the method for detecting food lipid
CN110470764A (en) * 2019-08-30 2019-11-19 天津云检医学检验所有限公司 A kind of semi-quantitative analysis method of lipid
CN110542730A (en) * 2019-08-30 2019-12-06 天津云检医学检验所有限公司 Absolute quantitative analysis method of ceramide
CN110596278A (en) * 2018-10-22 2019-12-20 嘉兴迈维代谢生物科技有限公司 Metabolite liquid chromatography-mass spectrometry combined detection method
CN111435132A (en) * 2019-01-15 2020-07-21 武汉艾迪康医学检验所有限公司 Lysophosphatidylcholine detection kit and detection method
CN111679026A (en) * 2020-06-17 2020-09-18 中国农业科学院农业质量标准与检测技术研究所 A cellular lipidomic analysis method based on ultra-high performance liquid chromatography tandem high-resolution mass spectrometry
CN111721859A (en) * 2020-06-05 2020-09-29 珠海沅芷健康科技有限公司 Early Alzheimer disease mouse lipidomics analysis method based on ultra-high performance liquid phase tandem high-resolution mass spectrometry and application
CN111830186A (en) * 2020-09-04 2020-10-27 黄河三角洲京博化工研究院有限公司 Method for representing molecular weight distribution of polyketone by liquid chromatography-mass spectrometry
CN112129875A (en) * 2020-09-24 2020-12-25 中国农业科学院油料作物研究所 A mass spectrometry method for identifying chain-length isomers of phosphatidylcholine
CN112362771A (en) * 2020-10-29 2021-02-12 上海鹿明生物科技有限公司 Method for high-throughput analysis of plant secondary metabolites based on LCMS and application
CN112730638A (en) * 2020-11-25 2021-04-30 首都医科大学附属北京朝阳医院 Diabetes combined myocardial infarction metabolism marker, detection reagent and kit
CN112881567A (en) * 2020-12-31 2021-06-01 上海鹿明生物科技有限公司 Detection method and application of phospholipid compounds classified in high abundance and low abundance in cells
CN113295793A (en) * 2021-05-20 2021-08-24 复旦大学附属中山医院 Biomarker for predicting early diabetes and diabetes occurrence, detection method and application thereof
CN113834888A (en) * 2021-09-23 2021-12-24 大连润生康泰医学检验实验室有限公司 Accurate detection method and kit for 4 ceramides in blood
WO2022033576A1 (en) * 2020-08-14 2022-02-17 宝枫生物科技(北京)有限公司 Method for diagnosing acting of nervonic acid, and application thereof
CN114236016A (en) * 2022-01-21 2022-03-25 武汉迈特维尔生物科技有限公司 A rapid and accurate method for the determination of 48 free fatty acids in biological samples
CN114778734A (en) * 2022-04-22 2022-07-22 江南大学 Quantitative determination method and application of polar lipid
CN115201392A (en) * 2022-05-20 2022-10-18 澳优乳业(中国)有限公司 Method for detecting phospholipid in dairy product
US20230138381A1 (en) * 2020-11-27 2023-05-04 Hainan Medical University A lc-ms/ms method for measurement of aloesin in rat plasma

Cited By (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107085061A (en) * 2017-05-22 2017-08-22 天津市第三中心医院 The absolute quantification analysis method of lysophosphatidyl choline based on HPLC MS/MS detection platforms
CN107085061B (en) * 2017-05-22 2019-03-15 天津市第三中心医院 The absolute quantification analysis method of lysophosphatidyl choline based on HPLC-MS/MS detection platform
CN107389847A (en) * 2017-06-05 2017-11-24 中国农业科学院蜜蜂研究所 A kind of method of lipid component in quick analysis Bee Pollen
CN107389847B (en) * 2017-06-05 2020-01-07 中国农业科学院蜜蜂研究所 A method for rapid analysis of lipid components in bee pollen
CN107632095A (en) * 2017-09-19 2018-01-26 中山大学 A kind of detection method of crop glycolipid and phosphatide
CN109870536A (en) * 2017-12-05 2019-06-11 中国科学院大连化学物理研究所 A high-coverage lipidomic analysis method based on liquid chromatography-mass spectrometry
CN109870536B (en) * 2017-12-05 2021-08-10 中国科学院大连化学物理研究所 High-coverage lipidomics analysis method based on liquid chromatography-mass spectrometry
CN107957467A (en) * 2017-12-13 2018-04-24 上海景峰制药有限公司 A kind of method of lysophosphatidyl choline in separation determination pharmaceutical preparation
CN107957467B (en) * 2017-12-13 2021-02-26 上海景峰制药有限公司 Method for separating and measuring lysophosphatidylcholine in pharmaceutical preparation
CN109946390A (en) * 2017-12-20 2019-06-28 上海生物信息技术研究中心 A kind of combination of pulmonary cancer diagnosis marker and application
CN108181387A (en) * 2017-12-20 2018-06-19 烟台东诚药业集团股份有限公司 The new method of phospholipid fraction content detection in a kind of Curosurf bulk pharmaceutical chemicals
CN108845051A (en) * 2018-06-22 2018-11-20 中国农业科学院农业质量标准与检测技术研究所 A method of based on sphingolipid in UHPLC-QTrap MS detection zebra fish brain tissue
CN108845051B (en) * 2018-06-22 2021-07-06 中国农业科学院农业质量标准与检测技术研究所 A method for the detection of sphingolipids in zebrafish brain tissue based on UHPLC-QTrap MS
CN109001360A (en) * 2018-10-09 2018-12-14 南京财经大学 A kind of method of high-throughput detection phospholipid in lipid content
CN110596278B (en) * 2018-10-22 2021-06-22 嘉兴迈维代谢生物科技有限公司 Metabolite liquid chromatography-mass spectrometry combined detection method
CN110596278A (en) * 2018-10-22 2019-12-20 嘉兴迈维代谢生物科技有限公司 Metabolite liquid chromatography-mass spectrometry combined detection method
CN111435132A (en) * 2019-01-15 2020-07-21 武汉艾迪康医学检验所有限公司 Lysophosphatidylcholine detection kit and detection method
CN109813813A (en) * 2019-01-18 2019-05-28 中国农业科学院农业质量标准与检测技术研究所 Method for identifying UHT milk and reconstituted milk based on lipidome
CN109813813B (en) * 2019-01-18 2022-01-28 中国农业科学院农业质量标准与检测技术研究所 Method for identifying ultra-high temperature sterilized milk and reconstituted milk based on lipid group
CN109884200A (en) * 2019-02-22 2019-06-14 嘉兴迈维代谢生物科技有限公司 A kind of quick exploitation and the method for establishing standard items LC-MS database
CN110007032A (en) * 2019-04-30 2019-07-12 江南大学 A kind of phospholipid detection method and application
CN110243956A (en) * 2019-05-20 2019-09-17 北京三元食品股份有限公司 A kind of food lipids extraction and the method for detecting food lipid
CN110243956B (en) * 2019-05-20 2021-06-18 北京三元食品股份有限公司 Method for extracting and detecting food lipid
CN110068638B (en) * 2019-05-21 2021-11-26 中山大学孙逸仙纪念医院 Method for specifically separating and enriching acidic sphingolipids and glycosphingolipids in human serum
CN110068638A (en) * 2019-05-21 2019-07-30 中山大学孙逸仙纪念医院 A kind of method of acid sphingolipid and glycosphingolipid in special separation and concentration human serum
CN110542730A (en) * 2019-08-30 2019-12-06 天津云检医学检验所有限公司 Absolute quantitative analysis method of ceramide
CN110470764A (en) * 2019-08-30 2019-11-19 天津云检医学检验所有限公司 A kind of semi-quantitative analysis method of lipid
CN111721859A (en) * 2020-06-05 2020-09-29 珠海沅芷健康科技有限公司 Early Alzheimer disease mouse lipidomics analysis method based on ultra-high performance liquid phase tandem high-resolution mass spectrometry and application
CN111679026A (en) * 2020-06-17 2020-09-18 中国农业科学院农业质量标准与检测技术研究所 A cellular lipidomic analysis method based on ultra-high performance liquid chromatography tandem high-resolution mass spectrometry
WO2022033576A1 (en) * 2020-08-14 2022-02-17 宝枫生物科技(北京)有限公司 Method for diagnosing acting of nervonic acid, and application thereof
CN111830186B (en) * 2020-09-04 2022-12-06 黄河三角洲京博化工研究院有限公司 Method for representing molecular weight distribution of polyketone by liquid chromatography-mass spectrometry
CN111830186A (en) * 2020-09-04 2020-10-27 黄河三角洲京博化工研究院有限公司 Method for representing molecular weight distribution of polyketone by liquid chromatography-mass spectrometry
CN112129875A (en) * 2020-09-24 2020-12-25 中国农业科学院油料作物研究所 A mass spectrometry method for identifying chain-length isomers of phosphatidylcholine
CN112129875B (en) * 2020-09-24 2023-05-26 中国农业科学院油料作物研究所 Mass spectrometry method for identifying phosphatidylcholine chain length isomer
CN112362771A (en) * 2020-10-29 2021-02-12 上海鹿明生物科技有限公司 Method for high-throughput analysis of plant secondary metabolites based on LCMS and application
CN112730638A (en) * 2020-11-25 2021-04-30 首都医科大学附属北京朝阳医院 Diabetes combined myocardial infarction metabolism marker, detection reagent and kit
CN112730638B (en) * 2020-11-25 2022-07-29 首都医科大学附属北京朝阳医院 Diabetes combined myocardial infarction metabolism marker, detection reagent and kit
US12105070B2 (en) * 2020-11-27 2024-10-01 Hainan Medical University LC-MS/MS method for measurement of Aloesin in rat plasma
US20230138381A1 (en) * 2020-11-27 2023-05-04 Hainan Medical University A lc-ms/ms method for measurement of aloesin in rat plasma
CN112881567A (en) * 2020-12-31 2021-06-01 上海鹿明生物科技有限公司 Detection method and application of phospholipid compounds classified in high abundance and low abundance in cells
CN113295793A (en) * 2021-05-20 2021-08-24 复旦大学附属中山医院 Biomarker for predicting early diabetes and diabetes occurrence, detection method and application thereof
CN113834888A (en) * 2021-09-23 2021-12-24 大连润生康泰医学检验实验室有限公司 Accurate detection method and kit for 4 ceramides in blood
CN113834888B (en) * 2021-09-23 2022-06-28 大连润生康泰医学检验实验室有限公司 Accurate detection method and kit for 4 ceramides in blood
CN114236016A (en) * 2022-01-21 2022-03-25 武汉迈特维尔生物科技有限公司 A rapid and accurate method for the determination of 48 free fatty acids in biological samples
CN114778734A (en) * 2022-04-22 2022-07-22 江南大学 Quantitative determination method and application of polar lipid
CN114778734B (en) * 2022-04-22 2024-05-07 江南大学 A quantitative determination method for polar lipids and its application
CN115201392A (en) * 2022-05-20 2022-10-18 澳优乳业(中国)有限公司 Method for detecting phospholipid in dairy product
CN115201392B (en) * 2022-05-20 2023-12-15 澳优乳业(中国)有限公司 A method for detecting phospholipids in dairy products

Similar Documents

Publication Publication Date Title
CN106093227A (en) The LC-MS method of 113 kinds of lipids in a kind of high flux detection organism blood sample
Tao et al. Metabolomics identifies serum and exosomes metabolite markers of pancreatic cancer
Wolrab et al. Oncolipidomics: Mass spectrometric quantitation of lipids in cancer research
Ros-Mazurczyk et al. Serum lipid profile discriminates patients with early lung cancer from healthy controls
Guo et al. Probing gender-specific lipid metabolites and diagnostic biomarkers for lung cancer using Fourier transform ion cyclotron resonance mass spectrometry
CN108414660B (en) Application of group of plasma metabolism small molecule markers related to early diagnosis of lung cancer
US8653006B2 (en) Metabolite biomarkers for the detection of esophageal cancer using NMR
CN109725072A (en) A targeted qualitative and quantitative metabolomic analysis method for screening cancer biomarkers based on LC-MS/MS technology
CN107037144B (en) A kind of ultra performance liquid chromatography tandem mass spectrum method of target metabolic object content in detection body fluid
Zhu et al. Metabolomic analysis of exosomal-markers in esophageal squamous cell carcinoma
Baila-Rueda et al. Simultaneous determination of oxysterols, phytosterols and cholesterol precursors by high performance liquid chromatography tandem mass spectrometry in human serum
US9739780B2 (en) Metabolite biomarkers for the detection of liver cancer
Wu et al. Absolute quantitative imaging of sphingolipids in brain tissue by exhaustive liquid microjunction surface sampling–liquid chromatography–mass spectrometry
Dickinson et al. Mass spectrometry–based lipidomics of oral squamous cell carcinoma tissue reveals aberrant cholesterol and glycerophospholipid metabolism—A Pilot study
CN108680745A (en) Application process of the serum lipids biomarker in NSCLC early diagnosis
Matos Do Canto et al. Metabolomic profiling of breast tumors using ductal fluid
Seubnooch et al. Characterisation of hepatic lipid signature distributed across the liver zonation using mass spectrometry imaging
CN112183616B (en) Diagnostic marker and kit for diagnosis of glioma, screening method and construction method of glioma diagnostic model
Cao et al. Database-assisted global metabolomics profiling of pleural effusion induced by tuberculosis and malignancy
CN111896641B (en) Small molecule screening method and application of colorectal cancer-related estrogen plasma metabolism
Yang et al. A green and efficient pseudotargeted lipidomics method for the study of depression based on ultra-high performance supercritical fluid chromatography-tandem mass spectrometry
Zhong et al. Serum metabolomic study for the detection of candidate biomarkers of tuberculosis
ES2960011T3 (en) Cancer diagnosis method based on lipidomic analysis of a body fluid
Yang et al. Determination of amino acid metabolic diseases from dried blood spots with a rapid extraction method coupled with nanoelectrospray ionization mass spectrometry
Yifan et al. Global serum metabolomic and lipidomic analyses reveal lipid perturbations and potential biomarkers of the colorectal cancer by adenoma-carcinoma sequence

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161109